Viewing Study NCT03227432


Ignite Creation Date: 2025-12-24 @ 9:46 PM
Ignite Modification Date: 2026-01-05 @ 5:58 PM
Study NCT ID: NCT03227432
Status: WITHDRAWN
Last Update Posted: 2018-08-14
First Post: 2017-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Exploratory Study to Evaluate the Combination of Elotuzumab and Nivolumab With and Without Pomalidomide in Relapsed Refractory Multiple Myeloma
Sponsor: Dana-Farber Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module